Net profit surged 37.9% year-over-year due to a gain on sale of investment securities, while operating profit declined 2.3% amid higher expenses. Segment results were mixed, with Industrial Products and Sustainability showing sales growth, but Life Science and Fine Chemicals facing headwinds.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.